Cargando…
Retrospective evaluation of dexmedetomidine dosing in a cohort of neurologically injured obese critically ill patients
BACKGROUND: Dexmedetomidine is used in neurocritical care units (NCCUs) due to the light, dose-dependent sedation, and anxiolysis provided. It is unknown how to dose dexmedetomidine in obese patients. The primary objective is to assess the ability to achieve the goal Richmond Agitation Sedation Scal...
Autores principales: | He, Harrison, Atyia, Sara A., Smetana, Keaton S., May, Casey C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401559/ https://www.ncbi.nlm.nih.gov/pubmed/37547192 http://dx.doi.org/10.4103/ijciis.ijciis_74_22 |
Ejemplares similares
-
What’s New in Critical Illness and Injury Science? Weighing the evidence for dexmedetomidine dosing in critically ill patients with obesity
por: Hejal, Rana, et al.
Publicado: (2023) -
Relationship between dexmedetomidine dose and plasma dexmedetomidine concentration in critically ill infants: a prospective observational cohort study
por: Fujita, Yoshihito, et al.
Publicado: (2017) -
Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients
por: Iirola, Timo, et al.
Publicado: (2011) -
Facilitators and Barriers to Nursing Implementation of Continuous Glucose Monitoring (CGM) in Critically Ill Patients With COVID-19
por: Faulds, Eileen R., et al.
Publicado: (2021) -
Assessment of acute kidney injury in neurologically and traumatically injured intensive care patients receiving large vancomycin doses
por: May, Casey C., et al.
Publicado: (2018)